LOGC Shares Outstanding History



Below is a table of the LOGC shares outstanding history going back to 10/19/2018:

Date LOGC Shares Outstanding
10/19/201820.71M
11/30/201822.18M
3/31/201922.35M
5/10/201922.49M
8/8/201922.67M
11/7/201922.92M
3/10/202023.30M
5/7/202023.35M
6/3/202023.43M
8/6/202023.64M
11/5/202031.79M
3/9/202132.03M
5/5/202132.16M
7/30/202132.24M
11/8/202132.96M
2/25/202232.96M
5/10/202232.96M
8/9/202232.96M
11/8/202232.96M

Also see: LOGC Market Cap History
LOGC YTD Return
LOGC Historical Shares Outstanding:
+12.14% CAGR
LOGC Historical Shares Outstanding: +12.14% CAGR

Mouse over chart for data details
10/19/2018 ...11/8/2022
LogicBio Therapeutics is a clinical-stage genetic medicine company focused on genome editing and gene delivery platforms to address diseases from infancy through adulthood. Co.'s genome editing platform, GeneRide™, is an approach to gene insertion harnessing a cell's natural deoxyribonucleic acid repair process. Co.'s product candidate, LB-001, is a single-administration, genome editing therapy developed using its GeneRide technology for the treatment of methylmalonic acidemia in pediatric patients. Co.'s other product candidate, LB-401 is based on its GeneRide technology. LB-401 is a genome editing therapy being developed for the treatment of hereditary tyrosinemia type 1 in newborns. We show 19 historical shares outstanding datapoints in our coverage of LOGC's shares outstanding history.

Understanding the changing numbers of LOGC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LOGC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LOGC by allowing them to research LOGC shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree LOGC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
LogicBio Therapeutics (LOGC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

LOXO Shares Outstanding History
LPCN Shares Outstanding History
LPNT Shares Outstanding History
LPTX Shares Outstanding History
LQDA Shares Outstanding History
LRMR Shares Outstanding History
LSTA Shares Outstanding History
LTRN Shares Outstanding History
LUCD Shares Outstanding History
LUMO Shares Outstanding History
More Healthcare companies »

 

LOGC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.